Outset Medical (OM) Cash & Current Investments (2019 - 2026)

Outset Medical (OM) has reported Cash & Current Investments for 8 consecutive years, with $263.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 40.43% year-over-year to $263.2 million in Q2 2026; TTM through Jun 2026 was $263.2 million, a 40.43% increase from a year earlier, with the FY2025 full-year figure at $168.9 million, up 4.28% from the prior year.
• Cash & Current Investments was $263.2 million for Q2 2026 at Outset Medical, down from $286.6 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $440.4 million in Q1 2022 and troughed at $162.0 million in Q4 2024.
• A 5-year average of $244.4 million and a median of $228.9 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments slumped 43.41% in 2023 and surged 81.16% in 2025, its largest moves.
• Over 5 years, Cash & Current Investments stood at $290.8 million in 2022, then slipped by 28.94% to $206.7 million in 2023, then declined by 21.6% to $162.0 million in 2024, then climbed by 4.28% to $168.9 million in 2025, then soared by 55.78% to $263.2 million in 2026.
• The last three Cash & Current Investments figures came in at $263.2 million (Q2 2026), $286.6 million (Q1 2026), and $168.9 million (Q4 2025), per Business Quant data.